Daily chlorproguanil is an effective alternative to daily proguanil in the prevention of Plasmodium falciparum malaria in Kenya

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 88, Issue 3, 1994, Pages 319-320

  Nevill, C G ^a   Lury, J D ^b   Mosobo, M K ^b   Watkins, H M ^b   Watkins, W M ^b,c,d  

^a AMREF HEALTH AFRICA   (Kenya)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLORPROGUANIL; PROGUANIL;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

CHILD; CHLOROGUANIDE; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALARIA, FALCIPARUM; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 0028304547     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/0035-9203(94)90100-7     Document Type: Article

References (11)

1. Bygbjerg, I., Ravan, P., Roun, A., Falchs, H. & Hvidberg, E. F. (1987). Human pharmacokinetics of proguanil and its metabolites. Tropical Medicine and Parasitology, 38, 77-80.
2. Coosemans, M. H., Barutwanayo, M., Onori, E., Otoul, C., Gryseels, B. & Wery, M. (1987). Double-blind study to assess the efficacy of chlorproguanil given alone or in combination with chloroquine for malaria chemoprophylaxis in an area with Plasmodium falciparum resistance to chloroquine, pyrimethamine and cycloguanil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 151-156.
3. Mann, R. D. & Phillips-Howard, P. A., editors. (1989). Malaria in Britain: Past and present. Journal of the Royal Society of Tropical Medicine, 82, supplement 17, 488-492.
4. Mberu, E. K., Winstanley, P. A., Howells, R. E. & Watkins, W. M. (1993). Antifolate synergy against Plasmodium falciparum in vitro; a comparison of candidate combinations for therapeutic use in man. Annual Meeting of British Society for Parasitology, Leeds, UK, March 1993 (abstract).
5. Nevill, C. G., Watkins, W. M., Carter, J. Y. & Munafu, C. G. (1988). Comparison of mosquito nets, proguanil hydrochloride and placebo to prevent malaria. British Medical Journal, 297, 401-403.
6. Nevill, C. G., Hulleman, P., Watkins, W. M., Milner, R., Mo- sobo, M. & Peshu, N. (1990). Clinical rather than parasitological failure—a more appropriate measure of antimalarial resistance. A pilot study. Proceedings of the Annual kemriiketri Conference, February, Nairobi, Kenya, February 1990.
7. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R. & Howard, S. V. (1977). Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II Analysis and examples. British Journal of Cancer, 35, 1-39.
8. Ritschel, W. A. (1986). Handbook of Basic Pharmacokinetics, 3rd edition. Hamilton, Ontario: Drug Intelligence Publications.
9. Watkins, W. M., Brandling-Bennett, A. D., Oloo, A. J., Howells, R., Gilles, H. M. & Koech, D. K. (1987c). Inadequacy of chlorproguanil 20 mg per week as chemoprophylaxis for falciparum malaria in Kenya. Lancet, 1, 125-127.
10. Watkins, W. M., Chulay, J. D., Sixsmith, D. G., Spencer, H. C. & Howells, R. E. (1987b). A preliminary pharmacokinetic study of the antimalarial drugs proguanil and chlorproguanil. Journal of Pharmacy and Pharmacology, 39, 261-265.
11. Watkins, W. M., Howells, R. E., Brandling-Bennett, A. D. & Koech, D. K. (1987c). In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya to antimalarial drugs. American Journal of Tropical Medicine and Hygiene, 37, 445— 451.